1-3 of 3
Jacopo Olivieri, MD
Close
Sort by
Journal Articles

In Vitro Comparison of Different TKI Activity in T-Cell Populations: Selective Sparing of Treg By Nilotinib

Elena Marinelli Busilacchi, ScD, Andrea Costantini, MD, Nadia Viola, ScD, Benedetta Costantini, MD, Antonella Poloni, MD, Jacopo Olivieri, MD, Francesco Saraceni, MD, Giorgia Mancini, MD, Attilio Olivieri, MD
Journal: Blood
Blood (2016) 128 (22): 5774.
https://doi.org/10.1182/blood.V128.22.5774.5774
Published: 2016
Journal Articles

The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib

Elena Marinelli Busilacchi, ScD, Jacopo Olivieri, MD, Nadia Viola, ScD, Antonella Poloni, MD, Giorgia Mancini, MD, Francesco Saraceni, MD, Anna Campanati, MD, Gaia Goteri, MD, Silvia Svegliati, ScD, Armando Gabrielli, MD, Attilio Olivieri, MD
Journal: Blood
Blood (2016) 128 (22): 4597.
https://doi.org/10.1182/blood.V128.22.4597.4597
Published: 2016
Journal Articles

A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory

Guido Gini, MD, Caterina Bocci, MD, Michela Sampaolo, MD, Silvia Trappolini, MD, Sonia Cacciagiù, Jacopo Olivieri, MD, Attilio Olivieri, MD, Massimo Offidani, Serena Rupoli, MD, Antonella Poloni, MD, Anna Rita Scortechini, MD, Debora Capelli, MD, Mauro Montanari, MD, Ilaria Scortechini, MD, Pietro Leoni, Prof
Journal: Blood
Blood (2015) 126 (23): 5109.
https://doi.org/10.1182/blood.V126.23.5109.5109
Published: 2015